RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Earnings per share

TAKARA BIO INC.JP:4974

Market cap
¥94.8B
P/E ratio
-10.5x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 20258.7-29.67%
Mar 31, 202412.3-90.75%
Mar 31, 2023133-19.33%
Mar 31, 2022164.8+107.90%
Mar 31, 202179.3+149.97%
Mar 31, 202031.7+4.41%
Mar 31, 201930.4+56.68%
Mar 31, 201819.4+72.51%
Mar 31, 201711.2+1.44%
Mar 31, 201611.1+38.33%
Mar 31, 20158-35.92%
Mar 31, 201412.5-3.40%
Mar 31, 201312.9+42.83%
Mar 31, 20129.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)